DK1161562T3 - Deleterede sekvenser i M. bovis BCG/M. bovis eller M. tuberculosis, fremgangsmåde til påvisning af mykobakterier ved anvendelse af sekvenserne og vacciner - Google Patents

Deleterede sekvenser i M. bovis BCG/M. bovis eller M. tuberculosis, fremgangsmåde til påvisning af mykobakterier ved anvendelse af sekvenserne og vacciner

Info

Publication number
DK1161562T3
DK1161562T3 DK00910960T DK00910960T DK1161562T3 DK 1161562 T3 DK1161562 T3 DK 1161562T3 DK 00910960 T DK00910960 T DK 00910960T DK 00910960 T DK00910960 T DK 00910960T DK 1161562 T3 DK1161562 T3 DK 1161562T3
Authority
DK
Denmark
Prior art keywords
sequences
bovis
tuberculosis
vaccines
bcg
Prior art date
Application number
DK00910960T
Other languages
Danish (da)
English (en)
Inventor
Stewart Cole
Stephen Gordon
Roland Buchrieser-Brosch
Alain Billault
Thierry Garnier
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of DK1161562T3 publication Critical patent/DK1161562T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK00910960T 1999-03-16 2000-03-16 Deleterede sekvenser i M. bovis BCG/M. bovis eller M. tuberculosis, fremgangsmåde til påvisning af mykobakterier ved anvendelse af sekvenserne og vacciner DK1161562T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9903250A FR2791067B1 (fr) 1999-03-16 1999-03-16 Sequence deletees chez m.bovis bcg/m.ou m.tuberculosis, procede de detection des mycobacteries utilisant ces sequences et vaccins
PCT/FR2000/000637 WO2000055362A1 (fr) 1999-03-16 2000-03-16 Sequences deletees chez m. bovis bcg/m. bovis ou m. tuberculosis, procede de detection des mycobacteries utilisant ces sequences et vaccins

Publications (1)

Publication Number Publication Date
DK1161562T3 true DK1161562T3 (da) 2009-06-29

Family

ID=9543261

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00910960T DK1161562T3 (da) 1999-03-16 2000-03-16 Deleterede sekvenser i M. bovis BCG/M. bovis eller M. tuberculosis, fremgangsmåde til påvisning af mykobakterier ved anvendelse af sekvenserne og vacciner

Country Status (12)

Country Link
US (2) US8357493B2 (de)
EP (1) EP1161562B9 (de)
AT (1) ATE432360T1 (de)
AU (1) AU3298900A (de)
CA (1) CA2368088C (de)
CY (1) CY1109210T1 (de)
DE (1) DE60042268D1 (de)
DK (1) DK1161562T3 (de)
ES (1) ES2326358T3 (de)
FR (1) FR2791067B1 (de)
PT (1) PT1161562E (de)
WO (1) WO2000055362A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1338657B9 (de) * 2002-02-25 2007-10-10 Institut Pasteur Spezifisch vom Genom von Mycobacterium tuberculosis deletierte Sequenzen und deren Verwendung in der Diagnostik und als Vakzine
US20050058663A1 (en) * 2003-09-17 2005-03-17 Monif Gilles R. G. Mycobacterium avium subspecies paratuberculosis oral vaccine and methods
PT1922415E (pt) 2005-09-05 2014-02-25 Bio Rad Innovations Uso de rd9 e is6110 como ácidos nucleicos-alvo para o diagnóstico da tuberculose, e fornecimento de alvos is6110 e rd9 compatíveis com uma utilização multiplex
US8961989B2 (en) 2009-11-20 2015-02-24 Oregon Health & Science University Methods for producing an immune response to tuberculosis
US9128098B2 (en) 2012-10-31 2015-09-08 Gilles R. G. Monif Fuidi herd management and risk stratification methods
GB201314873D0 (en) * 2013-08-20 2013-10-02 Univ Cape Town Method for diagnosing tuberculosis in a urine sample
CN108949783B (zh) * 2017-05-19 2021-03-26 复旦大学 一种重组卡介苗及其应用
WO2019135567A1 (en) * 2018-01-05 2019-07-11 Seegene, Inc. . Method for determining the presence or absence of m. tuberculosis, m. bovis and m. bovis bcg in a sample
CN110129465B (zh) * 2019-05-22 2023-08-22 杭州优思达生物技术股份有限公司 一种海分枝杆菌核酸的快速检测方法及其试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656493A (en) * 1985-03-28 1997-08-12 The Perkin-Elmer Corporation System for automated performance of the polymerase chain reaction
FR2663033B1 (fr) * 1990-06-08 1992-09-04 Pasteur Institut Detection specifique du mycobacterium tuberculosis.
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
EP0937159A4 (de) 1996-02-08 2004-10-20 Affymetrix Inc Speziesbestimmung und phenotypische charakterisierung von mikroorganismen auf der basis eines chips
US6183957B1 (en) 1998-04-16 2001-02-06 Institut Pasteur Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library application to the detection of mycobacteria
US6294328B1 (en) * 1998-06-24 2001-09-25 The Institute For Genomic Research DNA sequences for strain analysis in Mycobacterium tuberculosis
US6291190B1 (en) * 1998-08-25 2001-09-18 The Board Of Trustees Of The Leland Stanford Junior University Molecular differences between species of the M. tuberculosis complex

Also Published As

Publication number Publication date
ATE432360T1 (de) 2009-06-15
CA2368088A1 (fr) 2000-09-21
US20130164749A1 (en) 2013-06-27
FR2791067A1 (fr) 2000-09-22
CA2368088C (fr) 2012-08-07
ES2326358T3 (es) 2009-10-08
US20050250120A1 (en) 2005-11-10
EP1161562B9 (de) 2011-09-28
CY1109210T1 (el) 2014-07-02
US8357493B2 (en) 2013-01-22
EP1161562A1 (de) 2001-12-12
AU3298900A (en) 2000-10-04
WO2000055362A1 (fr) 2000-09-21
EP1161562B1 (de) 2009-05-27
FR2791067B1 (fr) 2003-01-31
DE60042268D1 (de) 2009-07-09
PT1161562E (pt) 2009-07-03

Similar Documents

Publication Publication Date Title
CY1109210T1 (el) Διαγραφεισες αλληλουχιες στο μ. bovis bcg/m. bovis ΄η μ. tuberculosis, μεθοδος ανιχνευσεως μυκοβακτηριων που χρησιμοποιουν αυτες τις αλληλουχιες και εμβολια
DK1051506T4 (da) Fremgangsmåder til ekstraktion og isolering af bakterielle kapselpolysaccharider til anvendelse som vacciner eller bundet til proteiner som konjugatvacciner
CY1109652T1 (el) Lawsonia intracellularis ευρωπαϊκης προελευσεως και εμβολια, διαγνωστικοι παραγοντες και μεθοδοι χρησεως τους
AR054477A1 (es) Vacunas para inmunizacion contra helicobacter
DK0527760T3 (da) Fremgangsmåder og præparater til vaccination mod HIV
DK0851927T3 (da) Forbindelser til immunterapi og diagnosticering af tuberkulose
FI854143A0 (fi) Itsenäisiä replikointisekvenssejä Pichia-hiivakannoille
CY1106584T1 (el) Αλληλουχιες που εξαλειφονται ειδικα απο το γονιδιωμα του μυκοβακτηριου της φυματιωσης (mycobacterium tuberculosis ) και η χρηση τους στη διαγνωστικη και σαν εμβολια
WO2002033116A3 (en) Nucleic acid ligands to the prostate specific membrane antigen
CY1108255T1 (el) Μεθοδος για τη συνθεση μιας ενωσης βενζιμιδαζολης
Villarreal et al. Multivalent TB vaccines targeting the esx gene family generate potent and broad cell-mediated immune responses superior to BCG
AU2883897A (en) Spruce budworm antifreeze proteins, genes and methods of using same
DK1154791T3 (da) Neisseria-vaccinesammensætninger og fremgangsmåder
Blanchett et al. Intranasal immunization with Ag85B peptide 25 displayed on Lactococcus lactis using the PilVax platform induces antigen‐specific B‐and T‐cell responses
WO2004083448A3 (en) Molecular differences between species of the m.tuberculosis complex
ATE442858T1 (de) Nukleinsäureadjuvantien
WO2002044406A3 (en) Projection against mycobacterial infections
WO2004102199A3 (en) Method for selecting and producing vaccine components and vaccines based thereon
WO2003093416A3 (en) Protective antigens for the control of ixodes species infestations
FI971402A (fi) Menetelmä voimistettujen antigeenisten Helico-bacter-lajien ja niitä sisältävien rokotteiden valmistamiseksi
DK1227840T3 (da) Adjuverede, genetiske vacciner
Blaser et al. Antisera against a Peb1 antigen from campylobacter jejuni
BRPI0303416B8 (pt) processos de obtenção do lipopolissacarídeo de bordetella pertussis e de obtenção e preparação do lipídeo-a monofosforilado de bordetella pertussis, uso do lipídeo-a monofosforilado de bordetella pertussis e vacinas
ATE341613T1 (de) Fluordesoxyuridin-resistente streptococcus gordonii stämme
BR0303762A (pt) Processos de obtenção do lipopolissacarìdeo de bordetella pertussis e de obtenção e preparação do lipìdeo a monofosforilado de bordetella pertussis, e de uso do lipìdeo a monofosforilado de bordetella pertussus como adjuvante em imunizações e vacinas